If sublingual bioavailability is approximately 10%, the effective weekly dose is approximately 2.1mg

Seek urgent medical advice if you experience: A lump in your neck Any new swelling or mass in the thyroid area should be evaluated, particularly if it grows or becomes more noticeable over time Persistent hoarseness Voice changes lasting more than two weeks without an obvious cause (such as a recent cold) warrant investigation Difficulty swallowing (dysphagia) This may indicate thyroid enlargement or other neck pathology Breathing difficulties Particularly if associated with neck swelling Unexplained neck pain Persistent or severe pain in the thyroid region Severe, persistent abdominal pain Especially if radiating to the back and/or accompanied by vomiting, as this could indicate pancreatitis Right upper abdominal pain, fever or yellowing of the skin/eyes Possible signs of gallbladder disease Signs of dehydration Such as dizziness, reduced urination, or extreme thirst Routine monitoring and follow-up: Patients prescribed Saxenda should attend follow-up appointments as recommended by their prescribing clinician

It should be noted that dose-proportionality was assessed using only two dose levels (1 and 2 mg/kg), and the observed linearity in systemic exposure should be interpreted within this dose range
Insulin sensitivity peaks in the morning, and the GIP receptor activation from retatrutide may synergize with this natural morning peak to produce slightly better glucose handling
Zhang Y, Chen H, Feng Y, Liu M, Lu Z, Hu B, Chen L, Zhang Y, Liu J, Cai F, Zhao Y, Pan W, Liao X, Pan S, Bestard-Lorigados I, Wu Y, Song W (2025) Activation of AMPK by GLP-1R agonists mitigates Alzheimer-related phenotypes in transgenic mice
In 2022, Novo Nordisk is faced with a lawsuit when a group of 7 claimants are granted class action status centralized in Delaware citing severe intestinal damage as a result of taking Ozempic